Decoding Dihydroartemisinin Targets in Lung Cancer
In a groundbreaking study that promises to reshape the landscape of cancer therapeutics, researchers have unveiled novel molecular targets of ...
Tag: targeted therapies for NSCLC
Evaluating First-Line Treatments for EGFR NSCLC
In the rapidly evolving landscape of lung cancer treatment, a groundbreaking study has emerged, offering unprecedented insight into tailored first-line ...
Moffitt Research Reveals Complementary Approaches to Combat Resistance to KRAS G12C Inhibitors in Lung Cancer
In a groundbreaking advancement that could redefine therapeutic strategies for lung cancer, researchers at the Moffitt Cancer Center have published ...
Chemo and Immunotherapy in Non-EGFR Lung Cancer
In recent years, the landscape of non-small cell lung cancer (NSCLC) treatment has undergone a significant transformation, driven primarily by ...
Novel Antibody-Drug Conjugate Demonstrates Promising Efficacy in EGFR-Mutated NSCLC Patients
In a groundbreaking development presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!